Global health

Nordic Consulting Launches Cloud Innovation Lab to Accelerate Health System Digital Transformation in Collaboration with Microsoft Azure and Amazon Web Services (AWS)

Retrieved on: 
Monday, March 11, 2024
Technology, Hospitals, Consulting, Health Technology, Professional Services, Software, Internet, Managed Care, Health, Data Management, Cloud, Emergency, Microsoft, Azure, Conference, Lab, Global health, Health care, Consultant, Artificial intelligence, Outline, Digital health, Electronic health record, AWS, HIMSS, Amazon Web Services, Virtual reality, Video game

Nordic Consulting , a global health and technology consulting company, announced today the opening of its Cloud Innovation Lab at the HIMSS Global Health Conference.

Key Points: 
  • Nordic Consulting , a global health and technology consulting company, announced today the opening of its Cloud Innovation Lab at the HIMSS Global Health Conference.
  • Developed in collaboration with Microsoft Azure and Amazon Web Services (AWS) , the cloud innovation digital simulation lab demonstrates Nordic’s commitment to helping health systems prove the value of and accelerate the adoption of cloud solutions to enable digital transformation in healthcare.
  • Nordic plans to introduce virtual reality elements to further enrich client interaction with the technologies showcased within the Cloud Innovation Lab.
  • “Our priority is helping health systems take digital transformation from theory into practice,” said Kevin Erdal, Managing Director and Global Practice Leader, Digital Health at Nordic Consulting.

LOBOS 1707 TEQUILA PARTNERS WITH (RED) TO LAUNCH A LIMITED-EDITION REPOSADO BOTTLE TO SUPPORT LIFE-SAVING PROGRAMS THAT FIGHT AIDS

Retrieved on: 
Tuesday, April 2, 2024
AIDS, Partnership, RED, Ageing, Global health, Sherry, Mark R. Dybul, CCO, LOBOS, Wine, LeBron James, Solera, Tequila, PX

NEW YORK, April 2, 2024 /PRNewswire/ -- Today, Lobos 1707 Tequila & Mezcal, the ultra-premium agave spirit brand, announces the launch of their (LOBOS 1707)RED Limited-Edition Reposado Tequila in partnership with (RED).

Key Points: 
  • NEW YORK, April 2, 2024 /PRNewswire/ -- Today, Lobos 1707 Tequila & Mezcal, the ultra-premium agave spirit brand, announces the launch of their (LOBOS 1707)RED Limited-Edition Reposado Tequila in partnership with (RED).
  • Through the partnership, Lobos 1707 has committed to contribute $100,000 to the Global Fund to help strengthen global healthcare systems and fund life-saving programs in vulnerable communities.
  • Lobos 1707 Tequila & Mezcal was established as an independent spirits producer in 2020 by Founder and Chief Creative Officer, Diego Osorio, with investor, legendary athlete, and cultural icon LeBron James.
  • Lobos 1707's award-winning Reposado has been developed into a Limited-Edition (RED)-themed bottle, presenting its same ultra-premium bold liquid tied to this bolder mission to end AIDS.

CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results

Retrieved on: 
Thursday, March 28, 2024
PDT, Environment, Hip, Launch, Global health, SAN, Sleep, Sale, Acquisition, CARES Act, CBD, OTCQB, ERC, Beauty salon

"We are very pleased with our fiscal year 2023 results.

Key Points: 
  • "We are very pleased with our fiscal year 2023 results.
  • Our 44.3% gross margin in FY23 is significantly improved from 34.2% in FY22," stated Joseph Dowling, Chief Executive Officer of CV Sciences.
  • Sales for fiscal 2023 were $16.0 million, a decrease of 1.2% from $16.2 million in 2022.
  • The total number of units sold during fiscal 2023 decreased by 6.7%, partially offset by increases in average sales price per unit.

ECONOMY AND POLITICS AFFECT IMPACT INVESTORS

Retrieved on: 
Wednesday, March 27, 2024
Online, Culture, Generation X, Global health, Education, Ageing, Research, American Century Investments, American Century, Investment, Medical research, Century, Gen

KANSAS CITY, Mo., March 27, 2024 /PRNewswire/ -- In the seventh impact investing survey by the $240 billion* global asset manager American Century Investments, U.S. investors buck international trends as the only surveyed country where a growing number of respondents are willing to sacrifice returns to create a positive impact. Yet, the appeal of impact investing has declined in each country surveyed, including the U.S. The survey results offer multiple reasons for this decline in appeal, including market conditions, concerns about greenwashing and the sustainability backlash. Survey results go back to 2016 in the United States, 2019 in the U.K., 2020 in Germany, 2021 in Australia and 2022 in Singapore.

Key Points: 
  • 40% of U.S. respondents are willing to sacrifice returns in order to create a positive impact.
  • Overall, 67% of interested investors would sacrifice up to 10% of returns to create a positive impact, with 6-10% the most common range.
  • "In its earliest forms, impact investing often accepted lower expected returns to have a bigger impact, but our impact investment strategies emphasize sustainability-related attributes or outcomes in addition to delivering a financial return.
  • "A willingness to give up as much as 10% of an expected return shows that impact investors expect to earn competitive returns and are making rational choices to realize an impact emphasis in addition to a financial return."

Global Clinical Trials Connect Conference 2024: London, United Kingdom - May 28-29, 2024 - Registration Now Open

Retrieved on: 
Tuesday, March 26, 2024
Diagnosis, ChromeOS, External, Learning, Partnership, Global health, Bioethics, Pleasure, Biotechnology, Pharma, Pharmaceutical industry

DUBLIN, March 26, 2024 /PRNewswire/ -- The "Global Clinical Trials Connect 2024" conference has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, March 26, 2024 /PRNewswire/ -- The "Global Clinical Trials Connect 2024" conference has been added to ResearchAndMarkets.com's offering.
  • The Global Clinical Trials Connect 2024 will provide a platform to discuss on the futuristic advancements in clinical trials and clinical research.
  • This multidisciplinary program involves broad participation of people from clinical trials community from around the globe who are focused on learning more about clinical research, clinical trials planning and management.
  • It gives us a great pleasure in welcoming you to the Global Clinical Trials Connect 2024.

Clinical Trial Supply & Logistics Market Projected to Reach $41.04 billion by 2030 - Exclusive Report by 360iResearch

Retrieved on: 
Monday, March 25, 2024
Catalent, Medical device, Temperature, Growth, Prevalence, Face, Molecule, Thermo Fisher Scientific, Medication, CTSL, Pharmacy, Partnership, Intelligence, Imp, Conditional sentence, ICON, Global health, Research, Good manufacturing practice, IMP, Transport, ICON PLC, Placebo, Infosys, GMP, Excipient, Investment, Clinical trial, GDP, Drug development, API, Clinical data management, Table, Ageing, Parexel

"Global Growth Trends in Clinical Trial Supply & Logistics: Navigating Challenges, Driving Innovation"

Key Points: 
  • "Global Growth Trends in Clinical Trial Supply & Logistics: Navigating Challenges, Driving Innovation"
    Clinical trial supply and logistics (CTSL) is a critical backbone for conducting clinical studies worldwide, providing essential services, including planning, storing, managing, and distributing clinical trial materials (CTMs).
  • South America also sees increased adoption of clinical trial supply and logistics, fueled by its developing healthcare infrastructure.
  • We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Clinical Trial Supply & Logistics Market.
  • "Dive into the Clinical Trial Supply & Logistics Market Landscape: Explore 187 Pages of Insights, 582 Tables, and 26 Figures"

Clinical Trial Supply & Logistics Market Projected to Reach $41.04 billion by 2030 - Exclusive Report by 360iResearch

Retrieved on: 
Monday, March 25, 2024
Catalent, Medical device, Temperature, Growth, Prevalence, Face, Molecule, Thermo Fisher Scientific, Medication, CTSL, Pharmacy, Partnership, Intelligence, Imp, Conditional sentence, ICON, Global health, Research, Good manufacturing practice, IMP, Transport, ICON PLC, Placebo, Infosys, GMP, Excipient, Investment, Clinical trial, GDP, Drug development, API, Clinical data management, Table, Ageing, Parexel

"Global Growth Trends in Clinical Trial Supply & Logistics: Navigating Challenges, Driving Innovation"

Key Points: 
  • "Global Growth Trends in Clinical Trial Supply & Logistics: Navigating Challenges, Driving Innovation"
    Clinical trial supply and logistics (CTSL) is a critical backbone for conducting clinical studies worldwide, providing essential services, including planning, storing, managing, and distributing clinical trial materials (CTMs).
  • South America also sees increased adoption of clinical trial supply and logistics, fueled by its developing healthcare infrastructure.
  • We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Clinical Trial Supply & Logistics Market.
  • "Dive into the Clinical Trial Supply & Logistics Market Landscape: Explore 187 Pages of Insights, 582 Tables, and 26 Figures"

Kellye Walker Joins Deere & Company as Senior Vice President, Chief Legal Officer and Worldwide Public Affairs

Retrieved on: 
Monday, March 25, 2024
Health, BJ's Wholesale Club, Environment, Global health, John Deere, Diageo, Safety, Walker, Intellectual property, Loblaw Companies, Eastman Chemical Company, Management

MOLINE, lll., March 25, 2024 /PRNewswire/ -- Deere & Company (NYSE: DE) announced today that former Eastman Chemical Company executive, Kellye Walker, will join its leadership team as senior vice president, chief legal officer and worldwide public affairs, effective April 29.

Key Points: 
  • MOLINE, lll., March 25, 2024 /PRNewswire/ -- Deere & Company (NYSE: DE) announced today that former Eastman Chemical Company executive, Kellye Walker, will join its leadership team as senior vice president, chief legal officer and worldwide public affairs, effective April 29.
  • Previously, she was executive vice president and chief legal officer for Huntington Ingalls Industries, Inc., a global engineering and defense technology provider and America's largest military shipbuilder.
  • She also served as chief administrative officer at American Water Works Co., senior vice president and general counsel for Diageo North America, and senior vice president, general counsel, and secretary for BJ's Wholesale Club.
  • "Over the course of her career, Kellye has compiled an impressive record of experience and achievement," said John May, chairman & CEO of Deere & Company.

Hain Celestial Group Appoints Seasoned Executive Chad Marquardt as President of North America

Retrieved on: 
Monday, March 18, 2024
Clearasil, GPN, Health, Organization, Mead, Bradley University, Shopper marketing, Business administration, Global health, Unilever, Customer, Enfamil, Brand management, Reckitt, International finance, Mead Johnson, Drink, Hygiene, Hain Celestial Group, Marquardt, Snack, HAIN, Marketing, Management

HOBOKEN, N.J., March 18, 2024 /PRNewswire/ -- The Hain Celestial Group, Inc. (Nasdaq: HAIN), a leading global health and wellness company whose purpose is to inspire healthier living through better-for-you brands, announced today that it has named Chad Marquardt as President, North America.

Key Points: 
  • HOBOKEN, N.J., March 18, 2024 /PRNewswire/ -- The Hain Celestial Group, Inc. (Nasdaq: HAIN), a leading global health and wellness company whose purpose is to inspire healthier living through better-for-you brands, announced today that it has named Chad Marquardt as President, North America.
  • Reporting to Hain's President and Chief Executive Officer Wendy Davidson, Marquardt will be an appointed Executive Officer and will serve on the Executive Leadership Team.
  • "Chad brings to Hain deep strategic experience and expertise across sales, customer development, channel expansion and omnichannel brand building in the better-for-you consumer packaged goods space," said Wendy Davidson, President and Chief Executive Officer.
  • "I'm honored to join Hain at such a pivotal time in its multiyear transformation," said Marquardt.

Hain Celestial Group Appoints Seasoned Executive Chad Marquardt as President of North America

Retrieved on: 
Monday, March 18, 2024
Clearasil, GPN, Health, Organization, Mead, Bradley University, Shopper marketing, Business administration, Global health, Unilever, Customer, Enfamil, Brand management, Reckitt, International finance, Mead Johnson, Drink, Hygiene, Hain Celestial Group, Marquardt, Snack, HAIN, Marketing, Management

HOBOKEN, N.J., March 18, 2024 /PRNewswire/ -- The Hain Celestial Group, Inc. (Nasdaq: HAIN), a leading global health and wellness company whose purpose is to inspire healthier living through better-for-you brands, announced today that it has named Chad Marquardt as President, North America.

Key Points: 
  • HOBOKEN, N.J., March 18, 2024 /PRNewswire/ -- The Hain Celestial Group, Inc. (Nasdaq: HAIN), a leading global health and wellness company whose purpose is to inspire healthier living through better-for-you brands, announced today that it has named Chad Marquardt as President, North America.
  • Reporting to Hain's President and Chief Executive Officer Wendy Davidson, Marquardt will be an appointed Executive Officer and will serve on the Executive Leadership Team.
  • "Chad brings to Hain deep strategic experience and expertise across sales, customer development, channel expansion and omnichannel brand building in the better-for-you consumer packaged goods space," said Wendy Davidson, President and Chief Executive Officer.
  • "I'm honored to join Hain at such a pivotal time in its multiyear transformation," said Marquardt.